Amphoteric sterols and the use thereof in the production of pH-sensitive liposomes

Details for Australian Patent Application No. 2002302364 (hide)

Owner Novosom AG

Inventors Panzner, Steffen; Endert, Gerold; ElMokdad, Nasr; Fankhanel, Stefan

Agent Freehills

Pub. Number AU-B-2002302364

PCT Number PCT/EP02/01878

PCT Pub. Number WO2002/066489

Priority 101 09 898.7 21.02.01 DE

Filing date 21 February 2002

Wipo publication date 4 September 2002

Acceptance publication date 3 January 2008

International Classifications

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/28 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Steroids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07J 43/00 (2006.01) Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 101 09 898.7 21.02.01 DE

27 February 2003 Application Open to Public Inspection

  Published as AU-B-2002302364

3 January 2008 Application Accepted

  Published as AU-B-2002302364

1 May 2008 Standard Patent Sealed

12 May 2011 Assignment Registered

  Novosom AG The patent has been assigned to Marina Biotech, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002302365-MULTIPLE LASER CAVITY

2002302363-Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors